Research Article
Change in Antimicrobial Therapy Based on Bronchoalveolar Lavage Data Improves Outcomes in ICU Patients with Suspected Pneumonia
Table 3
Outcome measures of patients based on implementation of BAL report-directed antimicrobial modification.
| | Antimicrobial modified | value | Yes (n = 113) | No (n = 37) |
| Duration-related outcomes | Total duration of hospital stay (median, (IQR)) | 16 (12–25) | 20 (15–37) | 0.042 | Total duration of ICU stay (median, (IQR)) | 10 (7–15) | 15 (10–30) | 0.003 | Duration from admission to FB (median, (IQR)) | 6 (3–10) | 7 (5–11) | 0.502 | Duration from FB to discharge from ICU (median, (IQR)) | 6(3–10) | 7(5–11) | 0.111 | Duration from FB to discharge from hospital (median, (IQR)) | 6 (4–10) | 8 (5–13) | 0.064 |
| Clinical outcomes | Expired, n (%) | 23 (20.4) | 12 (32.4) | | Improved, n (%) | 82 (72.5) | 18 (48.7) | 0.018# | Unchanged, n (%) | 8 (7.1) | 7 (18.9) | |
|
|
Mann–Whitney U test; #chi-square test; IQR: interquartile range. |